Administration Routes in Research Multiple delivery methods have been investigated across various research applications: Oral administration Uniquely effective for AOD-9604 unlike most peptides
Unlike topical serums or surface-level treatments, glow peptide therapy works at the cellular level to trigger your bodys own regenerative processes
Common Side Effects Mild pain or redness at the injection site Temporary dizziness Serious Side Effects Allergic reaction (rare) Swelling or breathing difficulty Serious reactions are uncommon, but you should seek medical help if symptoms worsen
References Frontiers in Endocrinology (2021) Progress on the Function and Application of Thymosin 4 Annals of the New York Academy of Sciences Thymosin 4: roles in development, repair, and engineering of the cardiovascular system Frontiers in Pharmacology (2022) Pharmacokinetics, distribution, metabolism, and excretion of BPC-157 HSS Journal (2025) Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review Current Pharmaceutical Design (2018) Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract Journal of Orthopaedic Surgery and Research (2019) BPC 157 and its effects on tendon healing CDC (2024) Vaccine Administration: Subcutaneous (SUBCUT) Injection NCBI Bookshelf (2023) Administration of Parenteral Medications Nursing Skills CDC (NCHS) Laboratory Procedure Manual: C-Peptide in Serum (storage guidelines) Additional Research and Background These sources provide related context and are not presented as support for a specific statement above
The answer often comes down to peptide vs GLP-1 mechanism
